Author: DTS

Intermittent Fasting and Type 2 Diabetes: What You Should Know

Original Article: https://www.medscape.com/viewarticle/intermittent-fasting-and-type-2-diabetes-when-recommend-and-2025a1000he8

Understanding Intermittent FastingIntermittent fasting (IF) is a way of eating that focuses on when you eat rather than what you eat. It involves cycles of eating and fasting—such as only eating during a 6 to 10-hour … [Read More]

HHS to Launch Major Wearable Device Campaign

Original Article: https://www.medscape.com/s/viewarticle/us-health-secretary-kennedy-says-hhs-launch-campaign-2025a1000gzd

Understanding the Campaign

U.S. Health Secretary Robert F. Kennedy Jr. announced on June 24, 2025, that the Department of Health and Human Services (HHS) will soon roll out a nationwide campaign to promote the use of … [Read More]

Bariatric Surgery and Self‑Esteem: Does the Boost in Self-Esteem Last?

Original Article: https://www.medscape.com/viewarticle/bariatric-surgery-boosts-self-esteem-does-it-last-2025a1000he9

Early Gains in Confidence

A recent study reported that positive self‑esteem scores among individuals having bariatric surgery for obesity more than doubled—from about 34 before surgery to 76 at one year after their procedure—on a 0–100 … [Read More]

MHRA Urges Contraception With GLP-1 Weight-Loss Drugs

Original Article: https://www.medscape.com/viewarticle/mhra-urges-contraception-glp-1-weight-loss-drugs-2025a1000f8o?form=fpf

Regulator Warns: GLP-1 Weight-Loss Drugs and Pregnancy Don’t Mix

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has issued a strong warning for women using GLP-1 weight-loss drugs, saying they must use effective birth control at … [Read More]

Telemonitoring Boosts Glycemic Control in T2D

Original Article: https://www.medscape.com/viewarticle/telemonitoring-boosts-glycaemic-control-t2d-2025a1000da6?form=fpf

Smart Devices Help T2D Patients Spend More Time in Healthy Glucose Range

A new study from Denmark showed that using telemonitoring technology helped people with type 2 diabetes (T2D) manage their blood sugar better than standard care. … [Read More]

SGLT2 Inhibitors Linked to Lower Risk for AF in T2D

Original Article: https://www.medscape.com/viewarticle/sglt2-inhibitors-linked-lower-risk-af-t2d-2025a1000fej?form=fpf

Diabetes Drug Shows Unexpected Heart Perk

A recent study from Germany found that a medicine, commonly prescribed for people with type 2 diabetes (T2D), called an SGLT2 inhibitor may help lower the risk of developing atrial fibrillation … [Read More]

More Americans Are Choosing Talk Therapy Over Medication

Original Article: https://www.medscape.com/viewarticle/more-us-patients-choose-talk-therapy-over-psychotropics-2025a1000ber

More People Picking Therapy Over Pills

Between 2018 and 2021, more adults in the U.S. started choosing psychotherapy (talk therapy) without medications to treat their mental health issues. At the same time, fewer people relied only … [Read More]